Amanda Hinkle
Psychiatric/Mental Health · Chapmanville, WVNPI 1255658290
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 154 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 27.1% of the total. Reporting peaked in 2021 at $793 and has fallen 61.2% since, to $307 in 2025.
Across 154 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$707
- Bayer$231
- Johnson & Johnson$203
- Novo Nordisk$181
- Abbott$141
- Novartis$124
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,59799%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $707 |
| Bayer | 14 | $231 |
| Johnson & Johnson | 12 | $203 |
| Novo Nordisk | 11 | $181 |
| Abbott | 6 | $141 |
| Novartis | 6 | $124 |
| AstraZeneca | 7 | $111 |
| Lilly USA, LLC | 7 | $111 |
| Dexcom, Inc. | 4 | $80 |
| Alkermes, Inc. | 4 | $79 |
| GSK | 4 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Indivior Inc. | 2 | $58 |
| Braeburn Inc. | 3 | $57 |
| Boehringer Ingelheim | 3 | $55 |
| Lundbeck LLC | 2 | $38 |
| Averitas Pharma Inc. | 1 | $34 |
| Ironshore Pharmaceuticals Inc. | 2 | $32 |
| Amgen | 2 | $30 |
| Pfizer | 2 | $30 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Amarin Pharma, Inc. | 1 | $22 |
| Verona Pharma, Inc. | 1 | $20 |
| Evoke Pharma, Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$2,611 in reported general payments places this provider in the 80th percentile of 142 psychiatric/mental health providers in West Virginia.
See all psychiatric/mental health providers in West Virginia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buspirone Hcl | 40 | $430 |
| Doxepin Hcl | 29 | $338 |
| Aripiprazole | 34 | $281 |
| Prazosin Hcl | 28 | $280 |
| Fluoxetine Hcl | 36 | $251 |
| Lurasidone Hcl | 12 | $231 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 18 | $127 |
| Escitalopram Oxalate | 25 | $112 |
| Clonazepam | 11 | $24 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Chapmanville
- Jeremy SchreiberWheeling$1.7M
- Kimberly RittenhouseParkersburg$7K
- Michael SkaggsRipley$7K
- Larry RobertsonHuntington$6K
- Gwendolyn HuffmanSummersville$6K
- Summer DevolParkersburg$5K
- Osric Malone-PrioleauSaint Marys$5K
- Mercedes WeikleFort Gay$5K
- Shannon PembertonBarboursville$4K
- Cathy McGeeParkersburg$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.